• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

I-131在乳腺脂肪坏死中的摄取。

I-131 uptake in fat necrosis of the breast.

作者信息

Itani Malak, Lewis David H

机构信息

Department of Radiology, University of Washington Medical Center, Box 357115, 1959 NE Pacific St, Seattle, WA 98195, USA.

出版信息

Radiol Case Rep. 2016 Nov 23;12(1):161-167. doi: 10.1016/j.radcr.2016.10.018. eCollection 2017 Mar.

DOI:10.1016/j.radcr.2016.10.018
PMID:28228903
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5310263/
Abstract

I-131 uptake in the breast has been described with a variety of normal and pathologic conditions. We present the case of a 38-year-old female who received 317 millicuries of radioactive I-131 treatment for papillary thyroid carcinoma. Post-treatment scan demonstrated I-131 uptake in an area of fat necrosis in the breast.

摘要

在多种正常和病理情况下,均有关于碘-131在乳腺摄取的描述。我们报告一例38岁女性,她因乳头状甲状腺癌接受了317毫居里的放射性碘-131治疗。治疗后扫描显示碘-131在乳腺脂肪坏死区域摄取。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfb3/5310263/f60d7daf4545/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfb3/5310263/3712dec15ab9/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfb3/5310263/afeeaeec463e/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfb3/5310263/4b5f6b4b32ff/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfb3/5310263/d2184b534cb0/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfb3/5310263/97c752c8e1fc/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfb3/5310263/dc5be33e6ec7/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfb3/5310263/f60d7daf4545/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfb3/5310263/3712dec15ab9/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfb3/5310263/afeeaeec463e/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfb3/5310263/4b5f6b4b32ff/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfb3/5310263/d2184b534cb0/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfb3/5310263/97c752c8e1fc/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfb3/5310263/dc5be33e6ec7/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfb3/5310263/f60d7daf4545/gr7.jpg

相似文献

1
I-131 uptake in fat necrosis of the breast.I-131在乳腺脂肪坏死中的摄取。
Radiol Case Rep. 2016 Nov 23;12(1):161-167. doi: 10.1016/j.radcr.2016.10.018. eCollection 2017 Mar.
2
I-131 uptake in the breast from fat necrosis.脂肪坏死导致乳腺摄取碘-131。
Proc (Bayl Univ Med Cent). 2019 Feb 6;32(1):140-142. doi: 10.1080/08998280.2018.1519496. eCollection 2019 Jan.
3
An unusual case of papillary carcinoma of the thyroid with cutaneous and breast metastases only.仅伴有皮肤和乳腺转移的甲状腺乳头状癌罕见病例。
Eur J Endocrinol. 1997 Sep;137(3):267-9. doi: 10.1530/eje.0.1370267.
4
Sarcoidosis mimicking metastatic thyroid cancer following radioactive iodine therapy.放射性碘治疗后酷似转移性甲状腺癌的结节病
J Community Hosp Intern Med Perspect. 2015 Feb 3;5(1):26360. doi: 10.3402/jchimp.v5.26360. eCollection 2015.
5
Differentiated thyroid carcinoma: Incremental diagnostic value of I SPECT/CT over planar whole body scan after radioiodine therapy.分化型甲状腺癌:放射性碘治疗后I SPECT/CT相对于平面全身扫描的增量诊断价值。
Endocrine. 2017 Jun;56(3):551-559. doi: 10.1007/s12020-016-1086-3. Epub 2016 Sep 29.
6
Squamous cell carcinoma of the lung and pulmonary metastasis of papillary thyroid carcinoma: a case report.肺鳞状细胞癌与甲状腺乳头状癌肺转移:一例报告
J Med Case Rep. 2019 Aug 19;13(1):259. doi: 10.1186/s13256-019-2177-6.
7
Iodine Uptake Patterns on Post-ablation Whole Body Scans are Related to Elevated Serum Thyroglobulin Levels After Radioactive Iodine Therapy in Patients with Papillary Thyroid Carcinoma.甲状腺乳头状癌患者放射性碘治疗后,消融后全身扫描的碘摄取模式与血清甲状腺球蛋白水平升高有关。
Nucl Med Mol Imaging. 2016 Dec;50(4):329-336. doi: 10.1007/s13139-016-0421-1. Epub 2016 May 13.
8
Impact of Patient Age and Histological Type on Radioactive Iodine Avidity of Recurrent Lesions of Differentiated Thyroid Carcinoma.患者年龄和组织学类型对分化型甲状腺癌复发病灶放射性碘摄取的影响。
Clin Nucl Med. 2018 Jul;43(7):482-485. doi: 10.1097/RLU.0000000000002078.
9
The Treatment of Well-Differentiated Thyroid Carcinoma.高分化甲状腺癌的治疗
Dtsch Arztebl Int. 2015 Jun 26;112(26):452-8. doi: 10.3238/arztebl.2015.0452.
10
Histopathologic characterization of radioactive iodine-refractory fluorodeoxyglucose-positron emission tomography-positive thyroid carcinoma.放射性碘难治性氟脱氧葡萄糖正电子发射断层扫描阳性甲状腺癌的组织病理学特征
Cancer. 2008 Jul 1;113(1):48-56. doi: 10.1002/cncr.23515.

引用本文的文献

1
Radioiodine whole body scan pitfalls in differentiated thyroid cancer.分化型甲状腺癌的碘全身扫描陷阱。
Endocrine. 2024 Aug;85(2):493-508. doi: 10.1007/s12020-024-03754-y. Epub 2024 Mar 18.
2
Dosing Therapeutic Radiopharmaceuticals in Obese Patients.肥胖患者的治疗性放射性药物给药。
Int J Mol Sci. 2022 Jan 13;23(2):818. doi: 10.3390/ijms23020818.
3
Management of Incidental Breast Lesions Detected at Nuclear Medicine Examinations.核医学检查中偶然发现的乳腺病变的处理。

本文引用的文献

1
Sorafenib in metastatic thyroid cancer: a systematic review.索拉非尼治疗转移性甲状腺癌的系统评价
Oncologist. 2014 Mar;19(3):251-8. doi: 10.1634/theoncologist.2013-0362. Epub 2014 Feb 21.
2
To treat or not to treat: the role of adjuvant radioiodine therapy in thyroid cancer patients.是否治疗:辅助放射性碘治疗在甲状腺癌患者中的作用。
J Oncol. 2012;2012:707156. doi: 10.1155/2012/707156. Epub 2012 Nov 1.
3
False-positive uptake on radioiodine whole-body scintigraphy: physiologic and pathologic variants unrelated to thyroid cancer.
Radiol Imaging Cancer. 2020 Mar 20;2(2):e190037. doi: 10.1148/rycan.2020190037. eCollection 2020 Mar.
4
I-131 uptake in the breast from fat necrosis.脂肪坏死导致乳腺摄取碘-131。
Proc (Bayl Univ Med Cent). 2019 Feb 6;32(1):140-142. doi: 10.1080/08998280.2018.1519496. eCollection 2019 Jan.
5
Unusual Sites of Metastatic and Benign I 131 Uptake in Patients with Differentiated Thyroid Carcinoma.分化型甲状腺癌患者中I 131摄取的转移和良性异常部位
Indian J Endocrinol Metab. 2018 Nov-Dec;22(6):740-750. doi: 10.4103/ijem.IJEM_70_18.
放射性碘全身闪烁扫描中的假阳性摄取:与甲状腺癌无关的生理和病理变异
Am J Nucl Med Mol Imaging. 2012;2(3):362-85. Epub 2012 Jul 10.
4
False-positive lesions mimicking breast cancer on FDG PET and PET/CT.假阳性病变在 FDG PET 和 PET/CT 上模拟乳腺癌。
AJR Am J Roentgenol. 2012 Mar;198(3):W304-14. doi: 10.2214/AJR.11.7130.
5
Hyperprolactinemia-related ¹³¹I uptake in nonlactating breasts.高催乳素血症相关的非哺乳期乳房¹³¹I摄取
Clin Nucl Med. 2012 Mar;37(3):e57-8. doi: 10.1097/RLU.0b013e318233639d.
6
Treatment with tyrosine kinase inhibitors for patients with differentiated thyroid cancer: the M. D. Anderson experience.接受酪氨酸激酶抑制剂治疗的分化型甲状腺癌患者:MD 安德森癌症中心的经验。
J Clin Endocrinol Metab. 2010 Jun;95(6):2588-95. doi: 10.1210/jc.2009-1923. Epub 2010 Apr 14.
7
The great mimicker: fat necrosis of the breast--magnetic resonance mammography approach.“伟大的模仿者”:乳腺脂肪坏死——磁共振乳腺造影方法
Curr Probl Diagn Radiol. 2009 Jul-Aug;38(4):189-97. doi: 10.1067/j.cpradiol.2009.01.001.
8
Radioactive iodine therapy in poorly differentiated thyroid cancer.放射性碘治疗在低分化甲状腺癌中的应用
Nat Clin Pract Oncol. 2007 Nov;4(11):665-8. doi: 10.1038/ncponc0979.
9
Enhancement of sodium/iodide symporter expression in thyroid and breast cancer.甲状腺癌和乳腺癌中钠/碘同向转运体表达的增强。
Endocr Relat Cancer. 2006 Sep;13(3):797-826. doi: 10.1677/erc.1.01143.
10
Poorly differentiated and anaplastic thyroid cancer.低分化及未分化甲状腺癌。
Cancer Control. 2006 Apr;13(2):119-28. doi: 10.1177/107327480601300206.